Sionna Therapeutics, Inc. (SION)
(Delayed Data from NSDQ)
$23.27 USD
+0.96 (4.30%)
Updated Sep 16, 2025 04:00 PM ET
After-Market: $23.23 -0.04 (-0.17%) 6:20 PM ET
2-Buy of 5 2
D Value C Growth B Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SION 23.27 +0.96(4.30%)
Will SION be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SION based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SION
All You Need to Know About Sionna Therapeutics, Inc. (SION) Rating Upgrade to Buy
Wall Street Analysts See a 66.51% Upside in Sionna Therapeutics, Inc. (SION): Can the Stock Really Move This High?
SION: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for SION
SION forms Non-ADX 1,2,3,4 Bullish on September 15
SION Fell Below 20 Day Moving Average on September 12
SION forms 20 Day Moving Average Support on September 11
SION forms 20 Day Moving Average Support on September 10
Stock Picks From Seeking Alpha's August 2025 New Analysts